View in EDS HTML Full Text PDF Full Text

Temozolomide based treatment in glioblastoma: 6 vs. 12 months.

Saved in:
Bibliographic Details
Title: Temozolomide based treatment in glioblastoma: 6 vs. 12 months.
Authors: Fasano, Morena1 (AUTHOR) morena.fasano@unicampania.it, Pirozzi, Mario1 (AUTHOR), De Falco, Vincenzo2 (AUTHOR), Miceli, Chiara Carmen1 (AUTHOR), Farese, Stefano1 (AUTHOR), Zotta, Alessia1 (AUTHOR), Famiglietti, Vincenzo1 (AUTHOR), Vitale, Pasquale2 (AUTHOR), Di Giovanni, Ilaria2 (AUTHOR), Brancati, Christian2 (AUTHOR), Carfora, Vincenzo3 (AUTHOR), Solari, Domenico4 (AUTHOR), Somma, Teresa4 (AUTHOR), Cavallo, Luigi Maria4 (AUTHOR), Cappabianca, Paolo4 (AUTHOR), Conson, Manuel5 (AUTHOR), Pacelli, Roberto5 (AUTHOR), Ciardiello, Fortunato1 (AUTHOR), Addeo, Raffaele2 (AUTHOR)
Source: Oncology Letters. Sep2024, Vol. 28 Issue 3, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17921074
DOI:10.3892/ol.2024.14551